Literature DB >> 18628450

RLIP76 and Cancer.

Sanjay Awasthi1, Sharad S Singhal, Yogesh C Awasthi, Bryan Martin, Jung-Hee Woo, C Casey Cunningham, Arthur E Frankel.   

Abstract

RLIP76 is a multifunctional membrane protein that transports glutathione conjugates of electrophilic compounds and other xenobiotics including chemotherapy agents out of cells. The protein is overexpressed in lung carcinomas, ovarian carcinomas, and melanomas. The protein also binds Ral and participates in mitotic spindle function, clathrin-dependent endocytosis, and triggers GTPase-activating protein activity. It is found throughout the cell, in membrane, cytosol, and the nucleus, and is known to shift between these compartments in response to stress. Loss of RLIP76 by antibody or antisense therapy is associated with increased sensitivity to radiation and chemotherapy. Conversely, liposomally delivered RLIP may treat poisoning and wounds.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18628450      PMCID: PMC2919285          DOI: 10.1158/1078-0432.CCR-08-0145

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  51 in total

1.  RLIP76 is the major ATP-dependent transporter of glutathione-conjugates and doxorubicin in human erythrocytes.

Authors:  R Sharma; S S Singhal; J Cheng; Y Yang; A Sharma; P Zimniak; S Awasthi; Y C Awasthi
Journal:  Arch Biochem Biophys       Date:  2001-07-15       Impact factor: 4.013

2.  A novel dinitrophenylglutathione-stimulated ATPase is present in human erythrocyte membranes.

Authors:  E F LaBelle; S V Singh; H Ahmad; L Wronski; S K Srivastava; Y C Awasthi
Journal:  FEBS Lett       Date:  1988-02-08       Impact factor: 4.124

3.  Purification and characterization of dinitrophenylglutathione ATPase of human erythrocytes and its expression in other tissues.

Authors:  R Sharma; S Gupta; S V Singh; R D Medh; H Ahmad; E F LaBelle; Y C Awasthi
Journal:  Biochem Biophys Res Commun       Date:  1990-08-31       Impact factor: 3.575

4.  RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance.

Authors:  Rajendra Sharma; Sharad S Singhal; Dilki Wickramarachchi; Yogesh C Awasthi; Sanjay Awasthi
Journal:  Int J Cancer       Date:  2004-12-20       Impact factor: 7.396

Review 5.  Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance.

Authors:  Sanjay Awasthi; Sharad S Singhal; Rajendra Sharma; Piotr Zimniak; Yogesh C Awasthi
Journal:  Int J Cancer       Date:  2003-09-20       Impact factor: 7.396

Review 6.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

Authors:  H Esterbauer; R J Schaur; H Zollner
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

7.  Dinitrophenyl S-glutathione ATPase purified from human muscle catalyzes ATP hydrolysis in the presence of leukotrienes.

Authors:  M Saxena; S S Singhal; S Awasthi; S V Singh; E F Labelle; P Zimniak; Y C Awasthi
Journal:  Arch Biochem Biophys       Date:  1992-10       Impact factor: 4.013

8.  The anionic conjugates of bilirubin and bile acids stimulate ATP hydrolysis by S-(dinitrophenyl)glutathione ATPase of human erythrocyte.

Authors:  S S Singhal; R Sharma; S Gupta; H Ahmad; P Zimniak; A Radominska; R Lester; Y C Awasthi
Journal:  FEBS Lett       Date:  1991-04-09       Impact factor: 4.124

9.  Purification and characterization of an ATPase from human liver which catalyzes ATP hydrolysis in the presence of the conjugates of bilirubin bile acids and glutathione.

Authors:  Y C Awasthi; S S Singhal; S Gupta; H Ahmad; P Zimniak; A Radominska; R Lester; R Sharma
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

10.  Dinitrophenyl glutathione efflux from human erythrocytes is primary active ATP-dependent transport.

Authors:  E F LaBelle; S V Singh; S K Srivastava; Y C Awasthi
Journal:  Biochem J       Date:  1986-09-01       Impact factor: 3.857

View more
  42 in total

Review 1.  Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signaling.

Authors:  Sharad S Singhal; Sharda P Singh; Preeti Singhal; David Horne; Jyotsana Singhal; Sanjay Awasthi
Journal:  Toxicol Appl Pharmacol       Date:  2015-10-23       Impact factor: 4.219

2.  Early Steps of Jaagsiekte Sheep Retrovirus-Mediated Cell Transformation Involve the Interaction between Env and the RALBP1 Cellular Protein.

Authors:  Margaux Monot; Alexandra Erny; Barbara Gineys; Sophie Desloire; Christine Dolmazon; Anne Aublin-Gex; Vincent Lotteau; Fabienne Archer; Caroline Leroux
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

3.  Targeting RLIP with CRISPR/Cas9 controls tumor growth.

Authors:  Jyotsana Singhal; Shireen Chikara; David Horne; Sanjay Awasthi; Ravi Salgia; Sharad S Singhal
Journal:  Carcinogenesis       Date:  2021-02-11       Impact factor: 4.944

Review 4.  Regulatory roles of glutathione-S-transferases and 4-hydroxynonenal in stress-mediated signaling and toxicity.

Authors:  Yogesh C Awasthi; Kota V Ramana; Pankaj Chaudhary; Satish K Srivastava; Sanjay Awasthi
Journal:  Free Radic Biol Med       Date:  2016-10-26       Impact factor: 7.376

5.  RLIP76 regulates HIF-1 activity, VEGF expression and secretion in tumor cells, and secretome transactivation of endothelial cells.

Authors:  Seunghyung Lee; Lawrence E Goldfinger
Journal:  FASEB J       Date:  2014-06-13       Impact factor: 5.191

6.  RalBP1 is necessary for metastasis of human cancer cell lines.

Authors:  Zhong Wu; Charles Owens; Nidhi Chandra; Kay Popovic; Mark Conaway; Dan Theodorescu
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

7.  P300 regulates the human RLIP76 promoter activity and gene expression.

Authors:  Archana Sehrawat; Sushma Yadav; Yogesh C Awasthi; Alakananda Basu; Charles Warden; Sanjay Awasthi
Journal:  Biochem Pharmacol       Date:  2013-02-16       Impact factor: 5.858

8.  RALBP1/RLIP76 depletion in mice suppresses tumor growth by inhibiting tumor neovascularization.

Authors:  Seunghyung Lee; Jeremy G T Wurtzel; Sharad S Singhal; Sanjay Awasthi; Lawrence E Goldfinger
Journal:  Cancer Res       Date:  2012-08-17       Impact factor: 12.701

9.  Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation.

Authors:  Pataje G S Prasanna; Deepa Narayanan; Kory Hallett; Eric J Bernhard; Mansoor M Ahmed; Gregory Evans; Bhadrasain Vikram; Michael Weingarten; C Norman Coleman
Journal:  Radiat Res       Date:  2015-08-18       Impact factor: 2.841

10.  Phosphoproteomics profiling of human skin fibroblast cells reveals pathways and proteins affected by low doses of ionizing radiation.

Authors:  Feng Yang; Katrina M Waters; John H Miller; Marina A Gritsenko; Rui Zhao; Xiuxia Du; Eric A Livesay; Samuel O Purvine; Matthew E Monroe; Yingchun Wang; David G Camp; Richard D Smith; David L Stenoien
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.